Rådgivande kommittén
Paul Johnson, MBChB MD FRCS
Director of Oxford Islet Transplant Programme and Professor of Paediatric Surgery, University of Oxford.
Paul Johnson qualified in medicine from the University of Leicester and subsequently trained in General Surgery in Leicester and Derby, followed by higher surgical training in Paediatric Surgery in Oxford, Melbourne, and Great Ormond Street Hospital in London.
Between 1993 and 1996 he was a Research Fellow in the Department of Surgery at the University of Leicester, where he undertook a project on the Isolation of Human Islets of Langerhans for Pancreatic Islet Transplantation. This led to a Doctorate of Medicine and started his ongoing interest in the field of Islet Transplantation for reversing Type 1 Diabetes. He was awarded a Hunterian Professorship from the Royal College of Surgeons of England for this research in 1998.
In 2002, Mr Johnson was appointed Director of the Islet Transplant Programme in Oxford. He is currently Chairman of the Research division of British Association of Paediatric Surgeons Research and Clinical Effectiveness Committee, Founder of the UK Academic Paediatric Surgeons Group and Co-Secretary of the International Pancreas and Islet Transplantation Association. He is also Clinical Tutor at St Edmund Hall.
He has an active research group and his research interests include ways of optimising the current methods used for islet isolation with particular reference to pancreatic structure and collagenase, and the developmental biology of the pancreas and foregut with particular relevance to the use of adult stem cells as an alternative source of islet tissue for transplantation.
In addition to islet transplantation, his clinical interests include the neonatal and paediatric pancreas (endocrine and exocrine), as well as other aspects of paediatric surgical gastroenterology.
Dr Julian Paul Hamilton-Shield MB,ChB, MD(Bristol), MRCP, FRCPCH
Senior Lecturer, University of Bristol.
Julian Shield qualified in 1985 and undertook his post-graduate training in Bristol and London. His early research mainly centred on Type 1 diabetes and rare forms of inherited diabetes. The epidemic of childhood obesity in the UK prompted a re-alignment of research interests to include the prevention and treatment of Type 2 diabetes and the "Metabolic Syndrome" in childhood. His clinical practice in diabetes, endocrinology and metabolism is based in one of the few, purpose built children’s hospitals in the United Kingdom. He is currently a Senior Lecturer in child health at the University of Bristol.
Professor Christian Berne
Christian Berne är professor i medicin, 
specialist i internmedicin och endokrinologi,
överläkare vid endokrin- och
diabetessektionen vid Akademiska
sjukhuset i Uppsala.
Christian Berne disputerade 1974. Han blev docent i histologi 1975 och i medicin 1982. Han utsågs till professor vid Uppsala universitet 1999.
Christian Berne arbetar med klinisk diabetesforskning, på senare år med fokus på typ 2-diabetes.
Professor Ulf Smith
Principal Investigator
Professor Smith is an expert in the pathogenesis of insulin resistance and type 2 diabetes. He focuses primarily on the role of adipose tissue in insulin resistance and the factors that contribute to the increase in cardiovascular diseases in patients with insulin resistance. He is Director of the Lundberg Laboratory and President of the European Association for the Study of Diabetes.
His research team focuses on the role of the adipose tissue in eliciting insulin resistance as well as the associated increase in cardiovascular morbidity and mortality. They have developed a broad methodological platform involving state-of-the-art technologies for phenotyping humans and experimental models involving transgenic animals or appropriate cell lines.
His team has coordinated two major EU-funded projects and is currently involved in other EU-funded projects.